The Starr Foundation conrinues its commitment to stem cell research with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), which will support and enhance collaborative, pioneering stem cell research at the three adjacent Manhattan campuses.
These studies are opening new avenues for understanding a range of health conditions, including developmental disorders, neurodegenerative diseases and cancer, laying the groundwork for the design of regenerative therapies to replenish tissues lost to illness or injury.
Read the Entire Article
A customized collection of news from foundations from around the Web.
William D. Eggers and Paul Macmillan of Dowser write about the social entrepreneurs slowly and steadily dirsupting the world of philanthropy. According to Forbes, philanthropy disruptors are those that believe “no one company is so vital that it can’t be replaced and no single business model too perfect to upend.”